Phase 1 study of TTC-352 in patients with metastatic breast cancer progressing on endocrine and CDK4/6 inhibitor therapy - Dudek, Arkadiusz Z.; Liu, Li C.; Fischer, James H.; Wiley, Elizabeth L.; Sachdev, Jasgit C.; Bleeker, Jonathan; Hurley, Randolph W.; Tonetti, Debra A.; Thatcher, Gregory R. J.; Venuti, Robert P.; O’Regan, Ruth M. (Breast cancer research and treatment, 2020)
Keywords: Antitumor activity; Aspartate; Aspartate transaminase; Breast cancer; Cancer; Cancer patients; Cancer research; Clinical Trial; Cyclin-dependent kinase 4; Diarrhea; Drug therapy; Embolism; Estrogen; Estrogen receptors; Medicine; Medicine & Public Health; Metastases; Metastasis; Myalgia; NCT; NCT03201913; Oncology; Oncology, Experimental; Patients; Pharmacokinetics; Protein kinase C; Pulmonary embolism; Stroma; Toxicity; Transaminase; Tumors; Estrogen receptor; TTC-352; Phase 1 study; Refractory breast cancer